Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein C pseudogene 8 (HNRNPCP8)

Target
HNRNPCP8
Molecular classification
Other (pseudogene)
01

Overview

Heterogeneous nuclear ribonucleoprotein C pseudogene 8 (HNRNPCP8) is a human processed pseudogene—a gene-derived DNA sequence that closely resembles the functional HNRNPC gene but typically lacks the regulatory elements and coding potential to produce a functional protein[1][6]. HNRNPCP8 is not known to produce protein nor directly influence biological pathways through protein function. Most pseudogenes, including HNRNPCP8, are considered non-coding, though some pseudogenes may regulate gene expression via RNA-based mechanisms, such as acting as competitive endogenous RNAs (ceRNAs) to sequester microRNAs or interact with RNA-binding proteins[3]. While pseudogenes have been implicated in various regulatory roles and sometimes linked to disease processes, there is currently no evidence supporting a direct pathological, biomarker, or therapeutic role for HNRNPCP8 specifically[1][6]. HNRNPCP8 is not a canonical drug target such as a receptor, enzyme, transporter, or transcription factor. Its function and potential significance, if any, are likely limited to the broader pseudogene regulatory landscape and not to direct biochemical targeting[1][3][6].

Other names
heterogeneous nuclear ribonucleoprotein C (C1/C2) pseudogeneHNRNPCP8
02

Biological functions

Potential regulatory roles through RNA mechanisms (e.g., as part of competitive endogenous RNA networks/ceRNA)May compete for miRNA or RNA-binding protein binding (theoretical, by analogy to other pseudogenes)
03

Disease associations

Other (no direct evidence specifically for HNRNPCP8, but pseudogenes can play roles in cancer and other diseases via regulatory RNA mechanisms)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein C pseudogene 8 (HNRNPCP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 8 (HNRNPCP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call